Pharmabiz32m
China NMPA grants expanded approval for Merck’s Gardasil for use in males 9-26 years of age to help prevent certain HPV-related cancers & diseases
China NMPA grants expanded approval for Merck’s Gardasil for use in males 9-26 years of age to help prevent certain HPV-related cancers & diseases: Rahway, New Jersey Friday, Ja ...
中国日报网5h
China administers its first dose of HPV vaccine for men
The recipient in Changsha, the capital of Hunan province, became the first man on the Chinese mainland to receive the HPV ...
Scancell’s Modi-1 Vaccine Shows Promising Early Results in Cancer Treatment
Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...